National pharmacy chain CVS is pulling the prescription heartburn drug Zantac, and the chain’s own in-house generic version of ranitidine, after traces of a cancer-causing ingredient were found in some of the products, CNBC reports.
Earlier this month, the Food and Drug Administration (FDA) found small amounts N-nitrosodimethylamine (NDMA), a compound that can cause cancer, in some medicines. Those medicines include ranitidine, which is the generic form of Zantac, as well as certain widely-used blood pressure medications. In the case of the blood-pressure drugs, recalls have led to shortages of the medicines.
In a statement, CVS noted that neither Zantac nor its generic version has been recalled by the FDA, nor is the federal agency recommending that patients top taking those medicines.
0 comments :
Post a Comment